First Time Loading...

Resapp Health Ltd
ASX:RAP

Watchlist Manager
Resapp Health Ltd Logo
Resapp Health Ltd
ASX:RAP
Watchlist
Price: 0.205 AUD Market Closed
Updated: Apr 27, 2024
Section:
 

Wall Street
Price Targets

RAP Price Targets Summary
Resapp Health Ltd

Wall Street analysts forecast RAP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RAP is 0.24 AUD .

RAP Lowest Forecast
Wall Street Target
Not Available
RAP Average Forecast
Wall Street Target
0.24 AUD
17% Upside
RAP Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
0.24 AUD
17% Upside
Highest
Price Target
Not Available
Resapp Health Ltd Competitors:
Price Targets
ICAD
ICAD Inc
235% Upside
AUGX
Augmedix Inc
117% Upside
G
688246
Goodwill E-Health Info Co Ltd
82% Upside
DOCS
Doximity Inc
27% Upside
ICAD
ICAD Inc
235% Upside
AUGX
Augmedix Inc
117% Upside
G
688246
Goodwill E-Health Info Co Ltd
82% Upside
DOCS
Doximity Inc
27% Upside
HSTM
HealthStream Inc
26% Upside
4DX
4DMedical Ltd
91% Upside
EQS
Equasens SA
53% Upside
C
CARA
Carasent ASA
82% Upside

Revenue
Forecast

Revenue Estimate
Resapp Health Ltd

The compound annual growth rate of Resapp Health Ltd's revenue for the next 2 years is 31%.

N/A
Past Growth
31%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Resapp Health Ltd

Operating Income forecast
is not available for
Resapp Health Ltd

Net Income
Forecast

Net Income Estimate
Resapp Health Ltd

Net Income forecast
is not available for
Resapp Health Ltd

See Also

Summary
RAP intrinsic value, competitors valuation, and company profile.
DCF Valuation
RAP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RAP stock valuation using valuation multiples.
Wall Street Estimates
RAP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RAP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RAP's stock price target?
Price Target
0.24 AUD

According to Wall Street analysts, the average 1-year price target for RAP is 0.24 AUD .

What is Resapp Health Ltd's Revenue forecast?
Projected CAGR
31%

The compound annual growth rate of Resapp Health Ltd's revenue for the next 2 years is 31%.

ALPHA SPREAD
Join more than 131,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.